Bay Shore Trust bought $966k of TELO
owner at Telomir Pharmaceuticals, Inc.. 138,000 shares at an average of $7.00, traded Feb 13, 2024, filed Feb 15, 2024.
Score components
- +12Role10% owner
- +25Trade size$966k at market
- 0Relative to holdingsHoldings up 2.6%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000897069-24-000395, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2024 | POpen-market purchase Common Stockindirect: By Trust | +49,000 | $7.00 | $343k | 5,455,431 | Feb 15, 2024 |
| Feb 13, 2024 | POpen-market purchase Common Stockindirect: See Footnote | +40,000 | $7.00 | $280k | 1,365,646 | Feb 15, 2024 |
| Feb 13, 2024 | POpen-market purchase Common Stockindirect: By Trust | +49,000 | $7.00 | $343k | 1,902,659 | Feb 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.